Showing results 9361 to 9380 of 14621
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 1997 | Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). | Litwin, Marek S.; Clark, Kristopher; Noack, Leanne; Fruze, Jill; Berndt, Michael C.; Albelda, Steven; Vadas, Mathew Alexander; Gamble, Jennifer R. |
| 2019 | Novel endosomal NOX2 oxidase inhibitor ameliorates pandemic influenza A virus-induced lung inflammation in mice | To, E.E.; Luong, R.; Diao, J.; O' Leary, J.J.; Brooks, D.A.; Vlahos, R.; Selemidis, S. |
| 2016 | Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies | Lewinsohn, M.; Brown, A.L.; Weinel, L.M.; Phung, C.; Rafidi, G.; Lee, M.K.; Schreiber, A.W.; Feng, J.; Babic, M.; Chong, C.E.; Lee, Y.; Yong, A.; Suthers, G.K.; Poplawski, N.; Altree, M.; Phillips, K.; Jaensch, L.; Fine, M.; D'Andrea, R.J.; Lewis, I.D.; et al. |
| 2016 | Novel insights into the effects of diabetes on gastric motility | Marathe, C.S.; Rayner, C.K.; Jones, K.L.; Horowitz, M. |
| 2021 | Novel ion channel targets and drug delivery tools for controlling glioblastoma cell invasiveness | Varricchio, A.; Ramesh, S.A.; Yool, A.J. |
| 2013 | Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: A multi-ethnic meta-analysis of 45,891 individuals | Dastani, Z.; Palmer, L.; Visscher, P.M.; Palmer, Lyle John |
| 2016 | Novel mechanisms in the pathogenesis of atrial fibrillation: Practical applications | Lau, D.; Schotten, U.; Mahajan, R.; Antic, N.; Hatem, S.; Pathak, R.; Hendriks, J.; Kalman, J.; Sanders, P. |
| 2003 | Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration | Zannettino, A.; Roubelakis, M.; Welldon, K.; Jackson, D.; Simmons, P.; Bendall, L.; Henniker, A.; Harrison, K.; Niutta, S.; Bradstock, K.; Watt, S. |
| 2021 | Novel method to select meaningful outcomes for evaluation in clinical trials | McLeod, C.; Norman, R.; Wood, J.; Mulrennan, S.; Morey, S.; Schultz, A.; Messer, M.; Spaapen, K.; Stoneham, M.; Wu, Y.; Smyth, A.; Blyth, C.; Webb, S.; Mascaro, S.; Woodberry, O.; Snelling, T. |
| 2023 | Novel modes of MPL activation in triple-negative myeloproliferative neoplasms | Samaraweera, S.E.; Geukens, T.; Casolari, D.A.; Nguyen, T.; Sun, C.; Bailey, S.; Moore, S.; Feng, J.; Schreiber, A.W.; Parker, W.T.; Brown, A.L.; Butcher, C.; Bardy, P.G.; Osborn, M.; Scott, H.S.; Talaulikar, D.; Grove, C.S.; Hahn, C.N.; D’Andrea, R.J.; Ross, D.M. |
| 2000 | Novel murine myeloid cell lines that exhibit a differentiation switch in response to IL-3 or GM-CSF, or to different constitutively active mutants of the GM-CSF receptor b subunit | McCormack, M.; Gonda, T. |
| 2019 | Novel mutations in NLGN3 causing autism spectrum disorder and cognitive impairment | Quartier, A.; Courraud, J.; Ha, T.; McGillivray, G.; Isidor, B.; Rose, K.; Drouot, N.; Savidan, M.-A.; Feger, C.; Jagline, H.; Chelly, J.; Shaw, M.; Laumonnier, F.; Gecz, J.; Mandel, J.-L.; Piton, A. |
| 2019 | Novel noninvasive assessment of microvascular structure and function in humans | Smith, K.J.; Argarini, R.; Carter, H.H.; Quirk, B.C.; Haynes, A.; Naylor, L.H.; McKirdy, H.; Kirk, R.W.; McLaughlin, R.A.; Green, D.J. |
| 2018 | Novel patient derived models reveal the impact of the tumor microenvironment on therapeutic response | Shafi, A.; Schiewer, M.; de Leeuw, R.; Dlygeri, E.; McCue, P.; Shah, N.; Gomella, L.; Lallas, C.; Trabulsi, E.; Centenera, M.; Hickey, T.; Butler, L.; Raj, G.; Tilley, W.; Cukierman, E.; Knudsen, K. |
| 2007 | A novel percutaneously adjustable device for ligature of the vertical vein in the setting of obstructive totally anomalous pulmonary venous connection | Chowdhury, Ujjwal K.; Mishra, Anand; Saxena, Anita; Kothari, Shyam S.; Malhotra, Amber; Mahajan, Rajiv; Honnakere, Jayanth H. V.; Venugopal, Panangipalli |
| 2010 | Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome | Jongmans, M.; Kuiper, R.; Carmichael, C.; Wilkins, E.; Dors, N.; Carmagnac, A.; Schouten-van Meeteren, N.; Li, X.; Stankovic, M.; Kamping, E.; Bengtsson, H.; Schoenmakers, M.; Geurts van Kessel, A.; Hoogerbrugge, P.; Hahn, C.; Brons, P.; Scott, H.; Hoogerbrugge, N. |
| 2017 | Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer | Ponnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R. |
| 2017 | Novel supports for Junior Medical Officers during out-of-hours work | Raith, E.P.; Roodenburg, O. |
| 2013 | Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations | Xu, H.; Yang, W.; Perez-Andreu, V.; Devidas, M.; Fan, Y.; Cheng, C.; Pei, D.; Scheet, P.; Burchard, E.; Eng, C.; Huntsman, S.; Torgerson, D.; Dean, M.; Winick, N.; Martin, P.; Camitta, B.; Bowman, W.; Willman, C.; Carroll, W.; Mullighan, C.; et al. |
| 2004 | Novel therapies | Peterson, D.; Beck, S.; Keefe, D. |
